Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pfizer

24.54
-0.3000-1.21%
Post-market: 24.540.00000.00%19:59 EDT
Volume:46.37M
Turnover:1.14B
Market Cap:139.52B
PE:17.74
High:24.95
Open:24.79
Low:24.46
Close:24.84
Loading ...

Pfizer Inc. Announces FDA Approval for TALZENNA and XTANDI Combination in HRR-Mutated Metastatic Castration-Resistant Prostate Cancer

Reuters
·
Yesterday

Pfizer Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Yesterday

Mixed options sentiment in Pfizer with shares down 0.46%

TIPRANKS
·
Yesterday

Pfizer’s Strategic Positioning in Breast Cancer Market and Growth Potential

TIPRANKS
·
13 Jun

Wells Fargo Sticks to Its Hold Rating for Pfizer (PFE)

TIPRANKS
·
13 Jun

US Senators Introduce Bill to Ban Direct-to-Consumer Drug Ads

MT Newswires Live
·
13 Jun

Trump Wants Cheaper Drugs Like Europe Has. How It Works. -- Barrons.com

Dow Jones
·
12 Jun

Create a Portfolio of Passive Income: 3 High-Yielding Dividend Stocks That Pay More Than 5%

Motley Fool
·
12 Jun

Mixed options sentiment in Pfizer with shares up 0.97%

TIPRANKS
·
12 Jun

Cantor Fitzgerald Remains a Hold on Pfizer (PFE)

TIPRANKS
·
10 Jun

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors. -- Barrons.com

Dow Jones
·
10 Jun

US Health Secretary to Revamp Vaccine Advisory Committee

MT Newswires Live
·
10 Jun

Bernstein Remains a Hold on Pfizer (PFE)

TIPRANKS
·
10 Jun

Pfizer Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
10 Jun

Pfizer call volume above normal and directionally bullish

TIPRANKS
·
09 Jun

Pfizer CEO Says No Deals Yet in US Drug Price Talks

MT Newswires Live
·
09 Jun

Pfizer CEO Says Under Mfn Co Could Rethink Drug Launch Strategy in Europe

THOMSON REUTERS
·
09 Jun

Pfizer CEO Says Co "Very Quickly" Looking at Deals for Obesity Assets, Says Lot of Players Emerging Particularly in China

THOMSON REUTERS
·
09 Jun

Pfizer CEO Says Meetings With Trump Administration on Mfn Were Cordial, Remained High Level and Did Not Dig Into Substance - Goldman Sachs Conference

THOMSON REUTERS
·
09 Jun

Pfizer CEO Albert Bourla Says the Trump Administration Has Had a Series of Meetings With Companies on Most Favored Nation Pricing

THOMSON REUTERS
·
09 Jun